Literature DB >> 1706592

Operational overlapping of cross-reactive and serotype-specific neutralization epitopes on VP7 of human rotavirus serotype 3.

N Kobayashi1, K Taniguchi, S Urasawa.   

Abstract

VP7-specific neutralizing monoclonal antibodies (N-MAbs) to serotype 3 human rotavirus were produced to analyze serotype 3-specific and cross-reactive neutralization epitopes on VP7. On the basis of the reactivity patterns in neutralization tests with various human and animal strains, a total of 10 N-MAbs could be classified into four groups; five antibodies specific to serotype 3 were divided into two groups, and five antibodies consisted of two groups which are cross-reactive with strain 69 M (serotype 8) or strain WI61 (serotype 9). Seven N-MAbs showed the same reactivity patterns to the virus strains in both neutralization tests and enzyme-linked immunosorbent assay (ELISA), while three N-MAbs specific to serotype 3 in neutralization showed a cross-reactivity with the serotype 8 strain in ELISA. Neutralization-resistant mutants of serotype 3 strains P and YO were selected by the N-MAbs. Cross-neutralization tests between the mutants and the MAbs indicated the presence of two serotype-specific (S1 and S2) and three cross-reactive (C1, C2, and C3) epitope groups. S1, S2, and C3 epitope groups overlapped operationally each other, and the S1 epitope group had an overlapping with the C1 epitope group. However, C2 epitope group identified by the MAbs which neutralized serotypes 3 and 9, had no operational overlapping with any other epitope groups.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1706592     DOI: 10.1007/bf01310493

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  41 in total

1.  Direct serotyping of human rotavirus in stools by an enzyme-linked immunosorbent assay using serotype 1-, 2-, 3-, and 4-specific monoclonal antibodies to VP7.

Authors:  K Taniguchi; T Urasawa; Y Morita; H B Greenberg; S Urasawa
Journal:  J Infect Dis       Date:  1987-06       Impact factor: 5.226

2.  Comparison of the amino acid sequences of the major neutralization protein of four human rotavirus serotypes.

Authors:  K Y Green; K Midthun; M Gorziglia; Y Hoshino; A Z Kapikian; R M Chanock; J Flores
Journal:  Virology       Date:  1987-11       Impact factor: 3.616

3.  Reassortant rotaviruses as potential live rotavirus vaccine candidates.

Authors:  K Midthun; H B Greenberg; Y Hoshino; A Z Kapikian; R G Wyatt; R M Chanock
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

4.  Identification of cross-reactive and serotype 2-specific neutralization epitopes on VP3 of human rotavirus.

Authors:  K Taniguchi; W L Maloy; K Nishikawa; K Y Green; Y Hoshino; S Urasawa; A Z Kapikian; R M Chanock; M Gorziglia
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

5.  Analysis of serotype-specific neutralization epitopes on VP7 of human rotavirus by the use of neutralizing monoclonal antibodies and antigenic variants.

Authors:  Y Morita; K Taniguchi; T Urasawa; S Urasawa
Journal:  J Gen Virol       Date:  1988-02       Impact factor: 3.891

6.  Serotype determination of human rotavirus isolates and antibody prevalence in pediatric population in Hokkaido, Japan.

Authors:  S Urasawa; T Urasawa; K Taniguchi; S Chiba
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

Review 7.  Rotaviruses: a review.

Authors:  M K Estes; E L Palmer; J F Obijeski
Journal:  Curr Top Microbiol Immunol       Date:  1983       Impact factor: 4.291

8.  Vaccinia virus recombinants expressing the SA11 rotavirus VP7 glycoprotein gene induce serotype-specific neutralizing antibodies.

Authors:  M E Andrew; D B Boyle; B E Coupar; P L Whitfeld; G W Both; A R Bellamy
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

9.  The rhesus rotavirus outer capsid protein VP4 functions as a hemagglutinin and is antigenically conserved when expressed by a baculovirus recombinant.

Authors:  E R Mackow; J W Barnett; H Chan; H B Greenberg
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

10.  Sequence analysis of the gene encoding the serotype-specific glycoprotein (VP7) of two new human rotavirus serotypes.

Authors:  K Y Green; Y Hoshino; N Ikegami
Journal:  Virology       Date:  1989-02       Impact factor: 3.616

View more
  2 in total

1.  Preparation and characterization of a neutralizing monoclonal antibody directed to VP4 of rotavirus strain K8 which has unique VP4 neutralization epitopes.

Authors:  N Kobayashi; K Taniguchi; T Urasawa; S Urasawa
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

2.  Characterization of the neutralizing epitopes of VP7 of the Gottfried strain of porcine rotavirus.

Authors:  S Y Kang; D A Benfield; M Gorziglia; L J Saif
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.